Reply to capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy?

D. J. Storey; M. Sakala; C. M. McLean; H. A. Phillips; L. K. Dawson; L. R. Wall; M. T. Fallon; S. Clive

doi:10.1093/annonc/mdq679

Reply to capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy?

D. J. Storey, M. Sakala, C. M. McLean, H. A. Phillips, L. K. Dawson, L. R. Wall, M. T. Fallon, S. Clive

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	240-241
Number of pages	2
Journal	Annals of Oncology
Volume	22
Issue number	1
DOIs	https://doi.org/10.1093/annonc/mdq679
Publication status	Published - Jan 2011

Access to Document

10.1093/annonc/mdq679

Cite this

@article{8d0a6f7b02714bf08d91e653b5480d86,

title = "Reply to capecitabine combined with oxaliplatin (CapOx) in clinical practice: how significant is peripheral neuropathy?",

author = "Storey, {D. J.} and M. Sakala and McLean, {C. M.} and Phillips, {H. A.} and Dawson, {L. K.} and Wall, {L. R.} and Fallon, {M. T.} and S. Clive",

year = "2011",

month = jan,

doi = "10.1093/annonc/mdq679",

language = "English",

volume = "22",

pages = "240--241",

journal = "Annals of Oncology",

issn = "0923-7534",